X
RMD icon

Xponance’s ResMed RMD Stock Holding History

Xponance’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.41M Sell
27,736
-1,693
-6% -$351K 0.03% 371
2026
Q1 		$6.61M Buy
29,429
+3,329
+13% +$830K 0.05% 294
2025
Q4 		$6.29M Buy
26,100
+1,409
+6% +$360K 0.05% 287
2025
Q3 		$6.76M Sell
24,691
-830
-3% -$227K 0.05% 267
2025
Q2 		$6.58M Sell
25,521
-3,540
-12% -$844K 0.06% 267
2025
Q1 		$6.51M Buy
29,061
+353
+1% +$82.4K 0.06% 245
2024
Q4 		$6.57M Sell
28,708
-2,564
-8% -$617K 0.06% 247
2024
Q3 		$7.63M Sell
31,272
-3,182
-9% -$711K 0.07% 216
2024
Q2 		$6.6M Sell
34,454
-12,552
-27% -$2.55M 0.07% 226
2024
Q1 		$9.31M Buy
47,006
+268
+0.6% +$49.1K 0.1% 177
2023
Q4 		$8.04M Buy
46,738
+3,363
+8% +$517K 0.1% 177
2023
Q3 		$6.41M Buy
43,375
+6,359
+17% +$1.15M 0.09% 193
2023
Q2 		$8.09M Buy
37,016
+4,478
+14% +$998K 0.11% 164
2023
Q1 		$7.13M Buy
32,538
+671
+2% +$146K 0.1% 180
2022
Q4 		$6.63M Buy
31,867
+3,121
+11% +$686K 0.11% 182
2022
Q3 		$6.28M Buy
28,746
+2,217
+8% +$505K 0.12% 151
2022
Q2 		$5.56M Buy
26,529
+3,638
+16% +$774K 0.11% 159
2022
Q1 		$5.55M Buy
22,891
+316
+1% +$76.4K 0.09% 181
2021
Q4 		$5.88M Buy
22,575
+1,990
+10% +$516K 0.09% 188
2021
Q3 		$5.42M Sell
20,585
-659
-3% -$180K 0.1% 173
2021
Q2 		$5.24M Buy
21,244
+91
+0.4% +$19.1K 0.1% 168
2021
Q1 		$4.1M Buy
21,153
+47
+0.2% +$9.43K 0.09% 194
2020
Q4 		$4.49M Buy
21,106
+356
+2% +$71K 0.1% 174
2020
Q3 		$3.56M Buy
20,750
+18
+0.1% +$3.32K 0.09% 189
2020
Q2 		$3.98M Buy
+20,732
New +$3.39M 0.1% 174

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Xponance's RMD Position: Q2 2026 in Review

Xponance reduced its ResMed (RMD) stake by 5.8% in Q2 2026, selling an estimated $351K and leaving 27,736 shares worth $5.41M. The position accounts for 0.03% of the portfolio, ranked #371.

Xponance first reported a position in RMD in Q2 2020 and has held it in 25 quarters since. The position peaked at $9.31M in Q1 2024. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Xponance held 27,736 shares of ResMed worth $5.41M as of Q2 2026.
  • Xponance sold 1,693 ResMed shares in Q2 2026, an estimated $351K.
  • ResMed made up 0.03% of Xponance's portfolio in Q2 2026, its #371 holding.
  • Xponance first reported a position in ResMed in Q2 2020 and has held it in 25 quarters since.
  • Xponance's ResMed position peaked at $9.31M in Q1 2024.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.